Anti-Human CSF2 Recombinant Antibody(Lenzilumab)
-
产品编号
YR1346
-
别名
科研级 Lenzilumab ( 仑兹鲁单抗 ), Anti-CSF2 Recombinant Antibody, Research Grade Lenzilumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Lenzilumab ( 仑兹鲁单抗 ), Anti-CSF2 Recombinant Antibody, Research Grade Lenzilumab |
Catalog Number | YR1346 |
Molecular Name | Lenzilumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG1 Kappa |
Formulation | PBS, pH7.5 |
Background | Lenzilumab (INN, development code KB003) is a humanized monoclonal antibody (class IgG1 kappa) that targets colony stimulating factor 2 (CSF2)/granulocyte-macrophage colony stimulating factor (GM-CSF). |
CAS Number | 1229575-09-0 |
Application | Neut, ELISA, IF, IP, FuncS, FCM, IHC, Block |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CSF2[Homo sapiens] |